Compound Detail
CHEMBL405130
WHI-P131 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL405130 |
| Name | WHI-P131 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | HOZUXBLMYUPGPZ-UHFFFAOYSA-N |
17
Targets
21
Activities
3
Assay Types
0
PK Parameters
20
Publications
3
Known Names
1
Mechanisms
Molecular Properties
297.3
MW (Da)
3.10
ALogP
6
HBA
2
HBD
76.5
PSA (Ų)
0.72
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Tyrosine-protein kinase JAK3 inhibitor | INHIBITOR | Tyrosine-protein kinase JAK3 | ✓ | ✓ |
Activity Summary
Kd 11 meas. best 5.97
IC50 8 meas. best 6.14
EC50 2 meas. best 5.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | IC50 | 6.14 | 6.14 | 720.0 | 1 |
| AP2-associated protein kinase 1 CHEMBL3830 | Kd | 5.97 | 5.97 | 1069.0 | 1 |
| Epidermal growth factor receptor CHEMBL203 | Kd | 5.93 | 5.93 | 1163.0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | Kd | 5.88 | 5.88 | 1313.0 | 1 |
| RAW CHEMBL614631 | IC50 | 5.85 | 5.85 | 1400.0 | 1 |
| NON-PROTEIN TARGET CHEMBL3879801 | EC50 | 5.82 | 5.725 | 1525.0 | 2 |
| Uncharacterized protein FLJ45252 CHEMBL4105933 | Kd | 5.81 | 5.81 | 1542.0 | 1 |
| L929 CHEMBL612267 | IC50 | 5.77 | 5.305 | 1700.0 | 2 |
| ALK tyrosine kinase receptor CHEMBL4247 | IC50 | 5.62 | 5.62 | 2400.0 | 1 |
| Serine/threonine-protein kinase 10 CHEMBL3981 | Kd | 5.58 | 5.58 | 2634.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 5.55 | 5.55 | 2800.0 | 1 |
| STE20-like serine/threonine-protein kinase CHEMBL4202 | Kd | 5.36 | 5.36 | 4373.0 | 1 |
| Ribosomal protein S6 kinase alpha-6 CHEMBL4924 | Kd | 5.23 | 5.23 | 5898.0 | 1 |
| Receptor-interacting serine/threonine-protein kinase 2 CHEMBL5014 | Kd | 5.23 | 5.23 | 5939.0 | 1 |
| Tyrosine-protein kinase JAK3 CHEMBL2148 | IC50 | 5.04 | 5.04 | 9100.0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | Kd | 4.66 | 4.66 | 21887.0 | 1 |
| Cyclin-G-associated kinase CHEMBL4355 | Kd | 4.54 | 4.54 | 28651.0 | 1 |
| Interleukin-1 receptor-associated kinase 4 CHEMBL3778 | Kd | 4.47 | 4.47 | 34145.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18024136 | 10.1016/j.bmc.2007.10.066 | Mus musculus | 17 |
| 18024136 | 10.1016/j.bmc.2007.10.066 | RAW | 7 |
| 29191878 | 10.1126/science.aan4368 | Unchecked | 5 |
| 18024136 | 10.1016/j.bmc.2007.10.066 | L929 | 5 |
| 17417631 | 10.1038/nchembio873 | NON-PROTEIN TARGET | 4 |
| 18024136 | 10.1016/j.bmc.2007.10.066 | HT-29 | 2 |
| 14593182 | 10.1126/science.1087061 | NON-PROTEIN TARGET | 1 |
| 29191878 | 10.1126/science.aan4368 | Mitogen-activated protein kinase kinase kinase 20 | 1 |
| - | 10.1039/C0MD00115E | Tyrosine-protein kinase JAK3 | 1 |
| - | 10.1039/C0MD00115E | Vascular endothelial growth factor receptor 2 | 1 |
| - | 10.1039/C0MD00115E | Vascular endothelial growth factor receptor 1 | 1 |
| - | 10.1039/C0MD00115E | Receptor tyrosine-protein kinase erbB-2 | 1 |
| - | 10.1039/C0MD00115E | Epidermal growth factor receptor | 1 |
| 21515061 | 10.1016/j.bmc.2011.04.008 | ALK tyrosine kinase receptor | 1 |
| 17417631 | 10.1038/nchembio873 | Unchecked | 1 |
| 14593182 | 10.1126/science.1087061 | T-cell | 1 |
| 14593182 | 10.1126/science.1087061 | Tyrosine-protein kinase JAK1 | 1 |
| 14593182 | 10.1126/science.1087061 | Tyrosine-protein kinase JAK2 | 1 |
| 14593182 | 10.1126/science.1087061 | Unchecked | 1 |
| 14593182 | 10.1126/science.1087061 | HFF | 1 |
Data from ChEMBL 36 via Core Engine